Aristotle University Of Thessaloniki (AUTH)
Ανοσοΐστοχημική και μοριακή διερεύνηση της οδού μεταγωγής σήματος του Notch στα καρκινώματα του μαστού με τριπλά αρνητικό ανοσοφαινότυπο
Abstract
dc:descriptionAim: The expression and/or activation of Notch pathway members have been several times implicated in the pathogenesis and progression of triple-negative breast cancer (TNBC), while trials with Notch inhibitors are ongoing. The aim of this study was to investigate the expression and subcellular localization of the less studied Notch receptors, Notch2 and Notch3, and of the Jagged1 (Jag1) ligand as also their association with the clinicopathological caharacteristics of the patients and their effect in the outcome in a series of patients with operable TNBC.Patients and Methods: We applied immunohistochemistry (IHC) for Notch2, Notch3 and Jag1 on TMAs from 333 TNBC. Membranous, cytoplasmic and nuclear localization were evaluated, indicative of inactive, semi-active and active states of the proteins, respectively. Patients had been treated with adjuvant anthracycline-based chemotherapy mostly within clinical trials.Results: Cytoplasmic (c-) Notch2, Notch3 and Jag1 were observed in 35%, 63% and 41% of the tumors, respectively; membranous (m-) Notch3 and nuclear (n-) Jag1 in 23% and 17%, respectively. Αll tumors with nuclear Jag1 (p<0.001) and the vast majority of those with cytoplasmic and membranous Notch3 (91.9%, p<0.001 and 95.5%, p=0.006, respectively) and cytoplasmic Notch2 (78.1%, p=0.045) were of the basal-like phenotype. None of these markers was individually associated with outcome. We obtained 4 clusters upon hierarchical clustering of continuous IHC values for prognostic evaluation: cluster 1, with tumors overexpressing nuclear Jag1 with various combinations of the rest of the markers; cluster 2, with complete absence of Notch3 and Jag1 expression; cluster 3, with absence of membranous Notch3 and nuclear Jag1; and, cluster 4, with strong membranous Notch3 but without nuclear Jag1. Upon multivariate analysis, in comparison to cluster 4, clusters 1, 2 and 3 conferred significantly higher risk for relapse (p-values <0.05).Conclusions: Notch2 and Notch3 may not be canonically activated, while the Jag1 ligand seems to be activated in about 17% of operable TNBC. Specific Notch3 and Jag1 subcellular localization patterns may provide clues for the behavior of the corresponding tumors, for possible benefit from conventional anthracycline-based adjuvant chemotherapy and potentially for Jag1 targeting.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Strati, Titika-Marina
- Στρατή, Τιτίκα-Μαρίνα
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42104